Marty Makary

Last updated

Marty Makary
Born
Martin Adel Makary

Liverpool, England, UK
Education
Medical career
ProfessionSurgeon
FieldAbdominal surgery
Sub-specialtiesIslet transplant surgery
Website www.hopkinsmedicine.org/profiles/details/martin-makary

Martin Adel Makary is a British-American surgeon, professor, author, and medical commentator. He practices surgical oncology and gastrointestinal laparoscopic surgery at the Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine, and teaches public health policy as Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health.

Contents

Makary is an advocate for disruptive innovation in medicine and physician-led initiatives, such as The Surgical Checklist, which he developed at Johns Hopkins and which was later popularized in Atul Gawande’s best-selling book The Checklist Manifesto . [1] Makary was named one of the most influential people in healthcare by HealthLeader magazine in 2013. [2] In 2018, Makary was elected to the National Academy of Medicine. [3]

During the COVID-19 pandemic, Makary was an early advocate for universal masking to control the pandemic and recommended vaccines for adults. [4] However, he was an outspoken opponent of broad COVID-19 vaccine mandates and, in late 2021 and early 2022, non-pharmaceutical interventions meant to reduce transmission in schools and universities. [5] [6]

Education

Makary was born in Liverpool, England, and moved to Baltimore as a young child. His family later moved to Danville, Pennsylvania, when his father took a job as a hematologist at the Geisinger Medical Center. Makary holds degrees from Bucknell University, Thomas Jefferson University and Harvard University. He was president of the student body at Harvard, and later served on the alumni board. He completed a Masters of Public Health (M.P.H.) degree, with a concentration in health policy.

Professional career

Makary completed a surgical residency at Georgetown University [7] in Washington D.C. where he also worked as a writer for The Advisory Board Company. Makary completed sub-specialty surgery training at Johns Hopkins in surgical oncology and gastrointestinal surgery under surgeon John Cameron, before joining Cameron's faculty practice as a partner. [8] In his first few years on the faculty at Johns Hopkins, Makary researched and wrote articles on the prevention of surgical complications. [9] He published on frailty [10] as a medical condition, and on safety and teamwork culture in medicine. Makary is the first author of the original scientific publications describing "The Surgery Checklist". [11] Makary worked with the World Health Organization [12] to develop the official World Health Organization Surgical Checklist. [1] For his contributions to the field of medicine, Makary was named Mark Ravitch Chair in Gastrointestinal Surgery, an endowed chair at the Johns Hopkins University School of Medicine, becoming the youngest endowed chair recipient at the time at the university. Three years later, he was named the Credentials Chair and Director of Quality and Safety for Surgery at Johns Hopkins. [7] In 2020, Makary was named Editor-in-Chief of MedPage Today. He was also appointed chief of the Johns Hopkins Islet Transplant Center, clinical lead for the Johns Hopkins Sibley Innovation Hub, Executive Director of Improving Wisely, a Robert Wood Johnson Foundation project to lower health care costs, is founder of the Johns Hopkins Center For Surgical Outcomes Research and Clinical Trials, and Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health. [13]

Makary is a pancreatic surgeon and has pioneered novel surgical procedures. He was awarded the Nobility in Science Award by the National Pancreas Foundation for performing the world's first series of laparoscopic pancreas islet transplant operations. [14] He has traveled with his international team overseas. [15] Makary specializes in advanced laparoscopic surgery and performed the first laparoscopic Whipple surgery at Johns Hopkins and the first laparoscopic Frey's procedure for pancreatitis. [16] [17]

Makary's research led to several partnerships, including a grant from the U.S. Department of Health and Human Services Agency for Healthcare Quality and Research, to study obesity treatment, [18] and a grant from the same agency to implement safety programs at 100 U.S. hospitals, a project he collaborated on with Peter Pronovost and the American College of Surgeons. Makary was also the lead author in the original paper introducing a Hospital Survey of Patient Safety Culture. [19]

He has written for The Wall Street Journal , [20] USA Today , Time, Newsweek , [21] and CNN, [22] and appears on NBC and Fox News. [23]

Makary has also called for the public reporting physician-endorsed quality measures by hospitals. [24] [25] He and Bryan Sexton have encouraged hundreds of hospitals to take the "Culture of Safety Survey" and make their results available to their communities. Makary also advocates for price transparency and has led efforts to ask hospitals to stop suing their low-income patients. [26]

In 2016, Makary and his colleagues exposed loopholes in the Orphan Drug Act accounting for higher drug pricing. His article "The Orphan Drug Act: Restoring the Mission to Rare Diseases", [27] covered by Kaiser Heath News, [28] led Senator Chuck Grassley's office to announce an investigation. [29]

COVID-19 pandemic

During the COVID-19 pandemic, Makary has been a proponent of treating the COVID-19 pandemic as a true public health threat, [30] masking, [31] vaccines and early vaccination strategies [32] that prioritized maximum coverage against severe disease similar to the UK vaccination strategy, and protection provided by natural immunity. [33] Dr. Makary has also been an outspoken opponent of vaccine mandates, various FDA & CDC policies, and restrictions at colleges and universities. [34]

In February 2020, Makary was vocal that the United States needed to take the threat of COVID-19 seriously and that people should stop all non-essential travel. He warned of disruptions to both the United States healthcare system and to people's daily lives. In addition Makary called for a national lockdown to help slow the spread of the virus and enable the healthcare system to respond and reduce morbidity and mortality. [35] In May 2020, Makary advocated for universal masking in an effort to enable businesses and schools to re-open to minimize economic and educational damage across the United States. [36] In May 2020, it was still debated by many in the scientific community as to whether masks provided much protection against infection, [37] [38] [39] however high-quality masking has proven an effective measure at limiting the spread of COVID-19. [40] [41]

In November 2020, Makary was critical of the pace at which the FDA were approving the mRNA vaccines from Pfizer. [42] Makary had taken issue with the speed at which various US government health organizations had taken to evaluate medications or perform COVID-19-based research. [43] In early February 2021, Makary advocated for prioritizing getting as many vaccinated with single doses versus holding vaccines back for second doses. [44] Single-dose vaccination strategies, like those used in the United Kingdom, [45] have shown to be effective [46] and conditions upon when to implement single-dose vaccination strategies have continued to be researched to assess optimal conditions for single or multiple doses. [47]

Makary stated in a February 2021 op-ed in The Wall Street Journal that "At the current trajectory" in the United States COVID-19 would "be mostly gone by April" 2021, primarily as a result of naturally acquired immunity. [48] The article's estimates of population immunity were criticized for being higher than the best available data supported. [49] On 1 May 2021, the national average 7 day case rate was 105 per 100,000, [50] a rate of community transmission the CDC described as "High Transmission" (the highest of four categories). [51]

Makary considers himself pro-vaccine but has also criticized vaccination mandates for populations other than healthcare workers. [52] Makary recommended a single-dose mRNA vaccine regimen for children 12-17 to minimize the occurrence of myocarditis as a reaction, contrary to the CDC's finding that the risks of infection "far outweigh" those of the two-dose vaccine schedule. [52] [53] In December 2021 he appeared on a podcast to argue against vaccine boosters, referring to himself as an "unboosted male" and saying that the SARS-CoV-2 Omicron variant was "nature's vaccine". [54]

Books

Makary is the author of the New York Times Best Selling book Unaccountable, in which he proposes that common sense, physician-led solutions can fix the healthcare system. [55] [56] The book was turned into the popular TV series, The Resident , which aired on Fox in 2018. [57] Makary is also the author of Mama Maggie a personal story about his distant relative Magda Gobran, a Nobel Peace Prize nominee working in the garbage slums of Cairo. [58] [59] [60] The Price We Pay, was released in 2018 and describes how business leaders can lower their health care costs and explores the grass-roots movement to restore medicine to its noble mission. [61] Makary is also the editor of the surgery textbook "General Surgery Review". [62] His latest book, Blind Spots, urges readers to think critically about today's medical consensuses. [63]

Awards and recognition

Makary is the recipient of numerous research and teaching awards, including the Best Teacher Award for Georgetown Medical School [15] and research awards from the Washington Academy of Surgery and the New England Surgical Society. He has been a visiting professor at over 30 U.S. medical schools and lectures frequently on innovation in health care. [64] In 2018, he was elected to the National Academy of Medicine. [65]

Related Research Articles

<span class="mw-page-title-main">Laparoscopy</span> Minimally invasive operation within the abdominal or pelvic cavities

Laparoscopy is an operation performed in the abdomen or pelvis using small incisions with the aid of a camera. The laparoscope aids diagnosis or therapeutic interventions with a few small cuts in the abdomen.

Asplenia refers to the absence of normal spleen function and is associated with some serious infection risks. Hyposplenism is used to describe reduced ('hypo-') splenic functioning, but not as severely affected as with asplenism.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots or the flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

<span class="mw-page-title-main">COVID-19 pandemic in the United States</span>

On December 31, 2019, China announced the discovery of a cluster of pneumonia cases in Wuhan. The first American case was reported on January 20, and Health and Human Services Secretary Alex Azar declared a public health emergency on January 31. Restrictions were placed on flights arriving from China, but the initial U.S. response to the pandemic was otherwise slow in terms of preparing the healthcare system, stopping other travel, and testing. The first known American deaths occurred in February and in late February President Donald Trump proposed allocating $2.5 billion to fight the outbreak. Instead, Congress approved $8.3 billion with only Senator Rand Paul and two House representatives voting against, and Trump signed the bill, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, on March 6. Trump declared a national emergency on March 13. The government also purchased large quantities of medical equipment, invoking the Defense Production Act of 1950 to assist. By mid-April, disaster declarations were made by all states and territories as they all had increasing cases. A second wave of infections began in June, following relaxed restrictions in several states, leading to daily cases surpassing 60,000. By mid-October, a third surge of cases began; there were over 200,000 new daily cases during parts of December 2020 and January 2021.

<span class="mw-page-title-main">COVID-19 vaccine</span> Vaccine against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on hospitals</span> Consequences of COVID-19 pandemic for hospitals

The COVID-19 pandemic has impacted hospitals around the world. Many hospitals have scaled back or postponed non-emergency care. This has medical consequences for the people served by the hospitals, and it has financial consequences for the hospitals. Health and social systems across the globe are struggling to cope. The situation is especially challenging in humanitarian, fragile and low-income country contexts, where health and social systems are already weak. Health facilities in many places are closing or limiting services. Services to provide sexual and reproductive health care risk being sidelined, which will lead to higher maternal mortality and morbidity. The pandemic also resulted in the imposition of COVID-19 vaccine mandates in places such as California and New York for all public workers, including hospital staff.

<span class="mw-page-title-main">Oxford–AstraZeneca COVID-19 vaccine</span> Viral vector vaccine for prevention of COVID-19

The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant and 61% against the Delta variant.

<span class="mw-page-title-main">Transmission of COVID-19</span> Mechanisms that spread coronavirus disease 2019

The transmission of COVID-19 is the passing of coronavirus disease 2019 from person to person. COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

Azeem Majeed is a Professor and Head of the Department of Primary Care & Public Health at Imperial College, London, as well as a general practitioner in South London and a consultant in public health. In the most recent UK University Research Excellence Framework results, Imperial College London was the highest ranked university in the UK for the quality of research in the “Public Health, Health Services and Primary Care” unit of assessment.

<span class="mw-page-title-main">Vaccine diplomacy</span> Use of vaccines as international diplomacy

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

<span class="mw-page-title-main">CoronaVac</span> Vaccine against COVID-19

CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.

<span class="mw-page-title-main">Pfizer–BioNTech COVID-19 vaccine</span> Type of vaccine for humans

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) that encodes a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial guidance recommended a two-dose regimen, given 21 days apart; this interval was subsequently extended to up to 42 days in the United States, and up to four months in Canada.

<span class="mw-page-title-main">COVID-19 vaccination in the United Kingdom</span> Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.

<span class="mw-page-title-main">COVID-19 vaccination in Israel</span> Plan to immunize against COVID-19

Israel's COVID-19 vaccination programme, officially named "Give a Shoulder", began on 19 December 2020, and has been praised for its speed, having given twenty percent of the Israeli population the first dose of the vaccines' two dose regimen in the span of three weeks.

<span class="mw-page-title-main">Deployment of COVID-19 vaccines</span> Distribution and administration of COVID-19 vaccinations

As of 12 August 2024, 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million vaccines were then being administered daily, only 22.3 percent of people in low-income countries had received at least a first vaccine by September 2022, according to official reports from national health agencies, which are collated by Our World in Data.

<span class="mw-page-title-main">Martin Kulldorff</span> Former professor of medicine, biostatistician

Martin Kulldorff is a Swedish biostatistician. He was a professor of medicine at Harvard Medical School from 2003 until his dismissal in 2024. He is a member of the US Food and Drug Administration's Drug Safety and Risk Management Advisory Committee and a former member of the Vaccine Safety Subgroup of the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention.

<span class="mw-page-title-main">COVID-19 vaccination in the Republic of Ireland</span> Immunisation plan against COVID-19

The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated, and was also ranked number one in the EU for the number of booster vaccines administered.

Peter Andrew McCullough is an American cardiologist. He was vice chief of internal medicine at Baylor University Medical Center and a professor at Texas A&M University. From the beginnings of the COVID-19 pandemic, McCullough has promoted misinformation about COVID-19, its treatments, and mRNA vaccines.

Fractional dose vaccination is a strategy to reduce the dose of a vaccine to achieve a vaccination policy goal that is more difficult to achieve with conventional vaccination approaches, including deploying a vaccine faster in a pandemic, reaching more individuals in the setting of limited healthcare budgets, or minimizing side effects due to the vaccine.

<span class="mw-page-title-main">COVID-19 vaccine misinformation and hesitancy</span> Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it

In many countries a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion, and law. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines are made, a story about COVID-19 being spread by 5G, and other false or distorted information. This misinformation, some created by anti-vaccination activists, has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize or coerce vaccination, such as lotteries, mandates, and free entry to events, which has in turn led to further misinformation about the legality and effect of these measures themselves.

References

  1. 1 2 Gawande, Atul (2009). The Checklist Manifesto . New York, NY: Metropolitan Books. pp.  101. ISBN   978-0-312-43000-9.
  2. ↑ Clark, Cherl (17 December 2013). "HL20: Martin Makary, MD—Pushing to Improve Transparency and Quality Standards". HealthLeader. Archived from the original on 10 January 2014.
  3. ↑ "Johns Hopkins Faculty Members Elected to National Academy of Medicine". Johns Hopkins Medicine Newsroom. 15 October 2018. Retrieved 18 October 2018.
  4. ↑ Makary, Martin (10 June 2021). "Opinion | Think Twice Before Giving the COVID Vax to Healthy Kids". www.medpagetoday.com. Retrieved 9 February 2022.
  5. ↑ Friedersdorf, Conor (5 January 2022). "Omicron and the Return to Normalcy". The Atlantic. Retrieved 25 January 2022.
  6. ↑ Ward, Myah (13 October 2021). "The Hopkins doc vs. the vaccine consensus". POLITICO. Retrieved 25 January 2022.
  7. 1 2 Hopkins, Johns. "Martin A. Makary M.D., M.P.H." Johns Hopkins Medicine. Johns Hopkins University. Retrieved 25 October 2011.
  8. ↑ Flynn, Ramsey. "Judgement Day". Hopkins Medicine Magazine. Retrieved 24 January 2012.
  9. ↑ Coldwell, Dr. "Medical Mistakes More Common Than You Think". Health.com. Archived from the original on 6 March 2014. Retrieved 24 January 2012.
  10. ↑ Makary, Martin A.; Segev, Dorry L.; Pronovost, Peter J.; Syin, Dora; Bandeen-Roche, Karen; Patel, Purvi; Takenaga, Ryan; Devgan, Lara; Holzmueller, Christine G. (June 2010). "Frailty as a predictor of surgical outcomes in older patients". Journal of the American College of Surgeons. 210 (6): 901–908. doi:10.1016/j.jamcollsurg.2010.01.028. ISSN   1879-1190. PMID   20510798.
  11. ↑ Makary, MA; Holzmueller, CG; Thompson, D; Rowen, L; Heitmiller, ES; Maley, WR; Black, JH; Stegner, K; Freischlag, JA; Ulatowski, JA; Pronovost, PJ (2006). "Operating room briefings: working on the same page". Jt Comm J Qual Patient Saf. 32 (6): 351–5. doi:10.1016/S1553-7250(06)32045-4. PMID   16776390.
  12. ↑ ExpertFile. "Dr. Marty Makary Physician, Researcher, Author, Medical Commentator - Expert with Johns Hopkins School of Medicine & Johns Hopkins Center for Global Health | ExpertFile". expertfile.com. Retrieved 6 July 2017.
  13. ↑ "Martin Adel Makary, M.D., M.P.H." hopkinsmedicine.org. The Johns Hopkins University. Retrieved 5 January 2022.
  14. ↑ "Martin Makary Receives National Pancreas Foundation's 2015 Nobility in Science Award - 10/28/2015" . Retrieved 6 July 2017.
  15. 1 2 Hopkins, John. "Martin Makary Faculty Directory Profile". Johns Hopkins. Retrieved 26 January 2012.
  16. ↑ Cohn, Meredith (29 June 2009). "Pancreatic cancer operation done laparoscopically". The Baltimore Sun. Retrieved 26 January 2012.
  17. ↑ Fan, Caleb J.; Hirose, Kenzo; Walsh, Christi M.; Quartuccio, Michael; Desai, Niraj M.; Singh, Vikesh K.; Kalyani, Rita R.; Warren, Daniel S.; Sun, Zhaoli (1 June 2017). "Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis". JAMA Surgery. 152 (6): 550–556. doi:10.1001/jamasurg.2016.5707. ISSN   2168-6262. PMC   5540049 . PMID   28241234.
  18. ↑ Maugh II, Thomas H. (30 June 2011). "Prompt reduction in use of medications for comorbid conditions after bariatric surgery". Obes Surg. 19 (12): 1646–56. doi:10.1007/s11695-009-9960-1. PMID   19763709. S2CID   9097138.
  19. ↑ Makary, Martin (2006). "Patient Safety in Surgery". Annals of Surgery. 243 (5): 628–32, discussion 632–5. doi:10.1097/01.sla.0000216410.74062.0f. PMC   1570547 . PMID   16632997.
  20. ↑ Makary, Marty (10 July 2014). "A Minimally Invasive Approach to Health-Care Reform". The Wall Street Journal.
  21. ↑ "The Daily Beast". The Daily Beast .
  22. ↑ Makary, Martin (28 December 2015). "Why our health care system is broken". CNN. Retrieved 28 December 2015.
  23. ↑ Makary, Marty (10 July 2015). "New FDA Warning". FOX News. Retrieved 10 July 2015.
  24. ↑ Reinberg, Steven. "Surgery on Wrong Patients, Surgical Sites Persists, Study Finds". Bloomberg Business Week. Archived from the original on 22 October 2010. Retrieved 26 January 2012.
  25. ↑ Makary, Marty (2007). "Operating Room Briefings and Wrong-Site Surgery" (PDF). Journal of the American College of Surgeons. 204 (2). American College of Surgeons: 236–43. doi:10.1016/j.jamcollsurg.2006.10.018. PMID   17254927 . Retrieved 26 January 2012.
  26. ↑ "When Hospitals Sue For Unpaid Bills, It Can Be 'Ruinous' For Patients". NPR.org. Retrieved 11 August 2019.
  27. ↑ Daniel, Michael G.; Pawlik, Timothy M.; Fader, Amanda N.; Esnaola, Nestor F.; Makary, Martin A. (2016). "The Orphan Drug Act: Restoring the Mission to Rare Diseases". American Journal of Clinical Oncology. 39 (2): 210–213. doi:10.1097/COC.0000000000000251. PMID   26580246. S2CID   26723799.
  28. ↑ "Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies". NPR.org. Retrieved 31 July 2017.
  29. ↑ "Sen. Grassley Launches Inquiry Into Orphan Drug Law's Effect On Prices". NPR.org. Retrieved 31 July 2017.
  30. ↑ Stankiewicz, Kevin (10 March 2020). "Johns Hopkins' Dr. Marty Makary on coronavirus: 'What happened in Wuhan could happen here'". CNBC. Retrieved 7 February 2022.
  31. ↑ Makary, Marty (14 May 2020). "Opinion | How to Reopen America Safely". The New York Times. ISSN   0362-4331 . Retrieved 7 February 2022.
  32. ↑ Makary, Marty (3 February 2021). "Dr. Marty Makary: Why first COVID vaccine dose is all I'll get for now". Fox News. Retrieved 7 February 2022.
  33. ↑ Makary, Marty (26 January 2022). "Opinion | The High Cost of Disparaging Natural Immunity to Covid". Wall Street Journal. ISSN   0099-9660 . Retrieved 8 February 2022.
  34. ↑ Ward, Myah (13 October 2021). "The Hopkins doc vs. the vaccine consensus". POLITICO. Retrieved 8 February 2022.
  35. ↑ Stankiewicz, Kevin (10 March 2020). "Johns Hopkins' Dr. Marty Makary on coronavirus: 'What happened in Wuhan could happen here'". CNBC. Retrieved 8 February 2022.
  36. ↑ Makary, Marty (14 May 2020). "Opinion | How to Reopen America Safely". The New York Times. ISSN   0362-4331 . Retrieved 8 February 2022.
  37. ↑ "Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza". www.who.int. Retrieved 8 February 2022.
  38. ↑ Xiao, Jingyi; Shiu, Eunice Y. C.; Gao, Huizhi; Wong, Jessica Y.; Fong, Min W.; Ryu, Sukhyun; Cowling, Benjamin J. (2020). "Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures - Volume 26, Number 5—May 2020 - Emerging Infectious Diseases journal - CDC". Emerging Infectious Diseases. 26 (5): 967–975. doi:10.3201/eid2605.190994. PMC   7181938 . PMID   32027586.
  39. ↑ Klompas, Michael; Morris, Charles A.; Sinclair, Julia; Pearson, Madelyn; Shenoy, Erica S. (21 May 2020). "Universal Masking in Hospitals in the Covid-19 Era". New England Journal of Medicine. 382 (21): e63. doi: 10.1056/NEJMp2006372 . ISSN   0028-4793. PMID   32237672. S2CID   214766754.
  40. ↑ Wang, Yuxin; Deng, Zicheng; Shi, Donglu (5 January 2021). "How effective is a mask in preventing COVID-19 infection?". Medical Devices & Sensors. 4 (1): e10163. doi:10.1002/mds3.10163. ISSN   2573-802X. PMC   7883189 . PMID   33615150.
  41. ↑ "Can face masks protect against COVID-19?". Mayo Clinic. Retrieved 8 February 2022.
  42. ↑ Creitz, Charles (30 November 2020). "Dr. Marty Makary blasts FDA timetable to approve coronavirus vaccine: 'Why are they waiting three weeks?'". Fox News. Retrieved 7 February 2022.
  43. ↑ Makary, Marty (13 September 2021). "Opinion | Covid Confusion at the CDC". Wall Street Journal. ISSN   0099-9660 . Retrieved 8 February 2022.
  44. ↑ Makary, Marty (3 February 2021). "Dr. Marty Makary: Why first COVID vaccine dose is all I'll get for now". Fox News. Retrieved 7 February 2022.
  45. ↑ Jones, Nick K.; Rivett, Lucy; Seaman, Shaun; Samworth, Richard J.; Warne, Ben; Workman, Chris; Ferris, Mark; Wright, Jo; Quinnell, Natalie; Shaw, Ashley; Cambridge COVID-19 Collaboration (8 April 2021). "Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection". eLife. 10: e68808. doi: 10.7554/eLife.68808 . ISSN   2050-084X. PMC   8064747 . PMID   33830018.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  46. ↑ Imai, Natsuko; Rawson, Thomas; Knock, Edward S; Sonabend, Raphael; Elmaci, Yasin; Perez-Guzman, Pablo N; Whittles, Lilith K; Kanapram, Divya Thekke; Gaythorpe, Katy A M; Hinsley, Wes; Djaafara, Bimandra A; Wang, Haowei; Fraser, Keith; FitzJohn, Richard G; Hogan, Alexandra B (9 February 2023). "Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study". The Lancet Public Health. 8 (3): e174–e183. doi:10.1016/S2468-2667(22)00337-1. ISSN   2468-2667. PMC   9910835 . PMID   36774945.
  47. ↑ Böttcher, Lucas; Nagler, Jan (20 October 2021). "Decisive Conditions for Strategic Vaccination against SARS-CoV-2". Chaos . 31 (101105): 101105. Bibcode:2021Chaos..31j1105B. doi:10.1063/5.0066992. PMC   7987045 . PMID   34717322. S2CID   240356527.
  48. ↑ Makary, Marty (18 February 2021). "Opinion: We'll Have Herd Immunity by April". Wall Street Journal. ISSN   0099-9660 . Retrieved 19 February 2021.
  49. ↑ Teoh, Flora (26 February 2021). "Misleading Wall Street Journal opinion piece makes the unsubstantiated claim that the U.S. will have herd immunity by April 2021". Science Feedback. Health Feedback. Retrieved 16 September 2024.
  50. ↑ "COVID Data Tracker". Centers for Disease Control and Prevention. 28 March 2020. Retrieved 8 February 2022.
  51. ↑ Christie, Athalia (2021). "Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage". MMWR. Morbidity and Mortality Weekly Report. 70 (30): 1044–1047. doi:10.15585/mmwr.mm7030e2. PMC   8323553 . PMID   34324480 . Retrieved 8 February 2022.
  52. 1 2 Ward, Myah (13 October 2021). "The Hopkins doc vs. the vaccine consensus". Politico . Retrieved 9 November 2021.
  53. ↑ "COVID-19 Vaccination". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 26 September 2022.
  54. ↑ Howard J (1 July 2022). "What's the Opposite of a Vaccine Selfie?". Science-Based Medicine.
  55. ↑ Makary, Marty (2012). Unaccountable : what hospitals won't tell you and how transparency can revolutionize health care (1st U.S. ed.). New York: Bloomsbury Press. ISBN   978-1-60819-836-8. OCLC   772106631.
  56. ↑ Cowles, Gregory. "Print & E-Books". The New York Times.
  57. ↑ Chase, Dave (17 January 2018). "The TV Series Hospital CEOs Don't Want You To See". Huffington Post. Retrieved 18 October 2018.
  58. ↑ Makary, Marty (2015). Mama Maggie: the untold story of one woman's mission to love the forgotten children of Egypt's garbage slums. Vaughn, Ellen Santilli. Nashville, Tennessee. ISBN   978-0-7180-2203-7. OCLC   883134560.{{cite book}}: CS1 maint: location missing publisher (link)
  59. ↑ Glenn, David (2015). "Mama Maggie: The Untold Story of One Woman's Mission to Love the Forgotten Children of Egypt's Garbage Slums". www.hopkinsmedicine.org. Retrieved 23 May 2022.
  60. ↑ Shaker, Nada (5 March 2020). "Egypt's Coptic philanthropist nominated for Nobel Prize - Al-Monitor: The Pulse of the Middle East". www.al-monitor.com. Retrieved 23 May 2022.
  61. ↑ Makary, Marty (2019). The Price We Pay: what broke American health care--and how to fix it. New York. ISBN   978-1-63557-411-1. OCLC   1057304737.{{cite book}}: CS1 maint: location missing publisher (link)
  62. ↑ Schäfer, Markus (1 April 2010). "Martin A. Makary (eds): General Surgery Review (2nd Edition)". World Journal of Surgery. 34 (4): 874. doi: 10.1007/s00268-010-0405-8 . ISSN   1432-2323.
  63. ↑ Makary, Marty. "Medicare’s crazy payment system is creating monopolies in health care," Washington Post, July 8, 2024. Retrieved Sept. 17. 2024. [This book is out on Sept. 17. 2024; this fact should be referenced with a better source once one exists.]
  64. ↑ "Marty Makary Profile". GoGoMag. Retrieved 26 January 2012.
  65. ↑ "National Academy of Medicine Elects 85 New Members". National Academy of Medicine. 15 October 2018. Retrieved 2 May 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.